Evidence map›Paper›PMID 36675016›Full record

ArticleInternational journal of molecular sciences2023

Changes in Lipidomics, Metabolomics, and the Gut Microbiota in CDAA-Induced NAFLD Mice after Polyene Phosphatidylcholine Treatment.

Jiayuan Zhang, Xiaoling Zang, Jinxiao Lv, Yicong Zhang, Zhihua Lv, Mingming Yu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. World journal of gastroenterology · 2025
    Article
  2. Article
  3. International journal of molecular sciences · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2023
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jiayuan ZhangSchool of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Xiaoling ZangSchool of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Jinxiao LvSchool of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Yicong ZhangSchool of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Zhihua LvSchool of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Mingming YuSchool of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.ORCID 0000-0001-9504-891X
Ocean University of China · CNQingdao National Laboratory for Marine Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in most parts of the world. Although there is no first-line drug approved for the treatment of NAFLD, polyene phosphatidylcholine (PPC) is used by clinicians to treat NAFLD patients. This study aimed to evaluate the efficacy of PPC on a mice model of NAFLD, and to study the PPC's mechanism of action. The mice were fed a choline-deficient, L-amino acid-defined (CDAA) diet to induce NAFLD and were subsequently treated with PPC. The treatment effects were evaluated by the liver index, histopathological examination, and routine blood chemistry analyses. Lipidomics and metabolomics analyses of 54 samples were carried out using ultraperformance liquid chromatography (UPLC) coupled to a mass spectrometer to select for changes in metabolites associated with CDAA diet-induced NAFLD and the effects of PPC treatment. The intestinal flora of mice were extracted for gene sequencing to find differences before and after the induction of NAFLD and PPC treatment. PPC significantly improved the CDAA diet-induced NAFLD condition in mice. A total of 19 metabolites including 5 polar metabolites and 14 lipids showed marked changes. In addition, significant differences in the abundance of

Indexed as

Gastrointestinal MicrobiomeNon-alcoholic Fatty Liver DiseaseAcetamidesAnimalsLipidomicsLiverMiceMice, Inbred C57BLPhosphatidylcholinesAcetamidesCDAAPhosphatidylcholinespolyene phosphatidylcholineCDAA-inducedgut microbiotalipidomicsmetabolomicsNAFLD

Identifiers

PMID36675016
PMCPMC9862520
OpenAlexW4315700891

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.